INS and Parkinson disease: This would also explain the treatment-induced benefits observed in conditions like Alzheimer’s and Parkinson’s Disease (AD, PD), as impaired cerebral metabolism and insulin responsiveness have been implicated in several neurodegenerative pathologies (33).